
10.18BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
NL0015002SN0
CUSIP
N72482123
Sector
Healthcare
Industry
Diagnostics & Research
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
26.65
PEG Ratio
1.32
Book Value
16.83
Dividend Share
0.35
Dividend Yield
0.71%
Earnings Share
1.85
Wall Street Target Price
49.77
EPS Estimate Current Year
2.49
EPS Estimate Next Year
2.67
EPS Estimate Current Quarter
0.6273
EPS Estimate Next Quarter
0.6541
Most Recent Quarter
-
Revenue TTM
2,115,649,024
Gross Profit TTM
1,416,466,048
EBITDA
751,241,984
Profit Margin
18.20%
Return On Assets TTM
5.65%
Return On Equity TTM
10.81%
Revenue Per Share TTM
10.246
Qtly Revenue Growth YOY
2.90%
Diluted Eps TTM
1.85
Qtly Earnings Growth YOY
-19.20%
Trailing PE
26.65
Forward PE
15
Price Sales TTM
4.8119
Price Book MRQ
2.9296
Enterprise Value Revenue
5
Enterprise Value EBITDA
15
23.77
0.00%274.16
-5.81%440.45
-3.77%170.00
-3.35%221.32
-2.87%77.00
-2.70%673.31
-2.50%673.65
-2.44%775.12
-2.29%245.82
-1.80%